Regulatory T cells and autoimmune hepatitis: What happens in the liver stays in the liver

Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapiesJournal of HepatologyVol. 61Issue 5PreviewAutoimmune hepatitis (AIH) is a chronic autoimmune liver disease usually requiring life-long immunosuppression. The mechanisms for disease initiation and chronicity are largely unknown. A contribution of deficient regulatory T cells (Tregs) in the blood was controversially discussed recently. So far investigations in the target organ have been limited to single parameter analysis in untreated AIH. Full-Text PDF Autoimmune hepatitis (AIH) is a classical autoimmune liver disease that has characteristic features of autoimmunity. It is more commonly seen in women, strongly associated with variants in the major histocompatibility complex region and usually responsive to immunosuppression. Although the aetiology is still unknown the development of the disease involves a loss of immunological self-tolerance to liver antigens resulting in a T cell mediated destruction of hepatocytes [[1]Tait B. Mackay I.R. Board P. Coggan M. Emery P. Eckardt G. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.Gastroenterology. 1989; 97: 479-481Abstract Full Text PDF PubMed Google Scholar]. The majority of AIH patients require lifelong immunosuppression to maintain remission and the treatment for AIH still relies on corticosteroids and azathioprine, which were first introduced more than 25 years ago [[2]Cook G.C. Mulligan R. Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.QJM. 1971; 40: 159-185Crossref PubMed Scopus (430) Google Scholar]. In recent years it has been suggested that one of the factors that predisposes to autoimmune disease is an imbalance between effector and regulatory arms of the immune system [3Sakaguchi S. Sakaguchi N. Asano M. Itoh M. Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol. 1995; 155: 1151-1164PubMed Google Scholar, 4Putnam A.L. Safinia N. Medvec A. Laszkowska M. Wray M. Mintz M.A. et al.Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.Am J Transplant. 2013; 13: 3010-3020Crossref PubMed Scopus (200) Google Scholar]. Evidence of this comes not only from clinical studies but also from animal studies in which defects in immune regulation and a lack of functional regulatory T cells (Tregs) is associated with the development of autoimmunity including autoimmune hepatitis. However, it is less clear whether the defect in patients with AIH is due to a failure of regulatory cell recruitment or function, or whether regulatory cells are simply overwhelmed by dominant effector cell responses. The article by Taubert and colleagues in this edition of the Journal of Hepatology sheds more light on this debate. They conducted a correlative study using immunohistochemistry and flow cytometry to quantify the relative proportions of effector cells, regulatory T cells and B cells in the liver and blood of patients with type1 AIH. Consistent with other studies they reported that intrahepatic Tregs are enriched in untreated type1 AIH but that their numbers fall in response to therapy. The authors suggest that this effect of therapy might explain the high relapse rates seen after discontinuation of immunosuppression in AIH and speculate that therapies that increase or preserve intrahepatic immunoregulation might be better suited for the long-term control of AIH.Lymphocytes comprise around 25% of intrahepatic immune cells and include effector CD4 T cells, cytotoxic T cells, B cells, invariant iNKT, and MAIT cells [[5]Racanelli V. Rehermann B. The liver as an immunological organ.Hepatology. 2006; 43: S54-S62Crossref PubMed Scopus (861) Google Scholar]. Regulatory networks particularly intrahepatic CD4+CD25highCD127lowFOXP3+ regulatory T cells control the effector responses. The intrahepatic frequency of these cells varies from 1% to 5% of the lymphocyte population in most chronic liver diseases [[6]Oo Y.H. Weston C.J. Lalor P.F. Curbishley S.M. Withers D.R. Reynolds G.M. et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol. 2010; 184: 2886-2898Crossref PubMed Scopus (171) Google Scholar] and is associated with a reversal of the CD4/CD8 ratio in the liver compared with blood [[7]Doherty D.G. O’Farrelly C. Innate and adaptive lymphoid cells in the human liver.Immunol Rev. 2000; 174: 5-20Crossref PubMed Scopus (307) Google Scholar]. In autoimmune hepatitis, CD4 T cells dominate in the early stage of the disease, particularly Th1 cells [[8]Lohr H.F. Schlaak J.F. Lohse A.W. Bocher W.O. Arenz M. Gerken G. et al.Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.Hepatology. 1996; 24: 1416-1421Crossref PubMed Google Scholar]. Subsequently, T helper cells recruit cytotoxic CD8 T cells leading to higher CD8 T cell frequencies and possibly more aggressive cytotoxic T cell mediated destruction of hepatocytes as the disease progresses as described by Taubert and colleagues [[9]Taubert R. Hardtke-Wolenski M. Noyan F. Wilms A. Baumann A.K. Schlue J. et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.J Hepatol. 2014; 61: 1106-1114Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar].Staining for the FOXP3 transcription factor, the master regulator of Treg differentiation and function has been widely used to quantify CD4 Tregs in tissues [[10]Fontenot J.D. Gavin M.A. Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.Nat Immunol. 2003; 4: 330-336Crossref PubMed Scopus (6020) Google Scholar]. However, FOXP3 is also expressed transiently during T cell activation and in some other lymphocyte subsets, potentially reducing the reliability of single colour immunohistochemistry to quantify Tregs in hepatic inflammation [6Oo Y.H. Weston C.J. Lalor P.F. Curbishley S.M. Withers D.R. Reynolds G.M. et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol. 2010; 184: 2886-2898Crossref PubMed Scopus (171) Google Scholar, 11Lan R.Y. Cheng C. Lian Z.X. Tsuneyama K. Yang G.X. Moritoki Y. et al.Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.Hepatology. 2006; 43: 729-737Crossref PubMed Scopus (258) Google Scholar]. The current report partially overcomes this by using double immunohistochemistry. However, in the inflamed environment some Tregs may display lineage plasticity and express both FOXP3 and the Th1 transcription factor TBet [[12]Yang X.O. Nurieva R. Martinez G.J. Kang H.S. Chung Y. Pappu B.P. et al.Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.Immunity. 2008; 29: 44-56Abstract Full Text Full Text PDF PubMed Scopus (898) Google Scholar] and high local levels of TGF-β and retinoic acid may generate induced Tregs [13Carambia A. Freund B. Schwinge D. Heine M. Laschtowitz A. Huber S. et al.TGF-beta-dependent induction of CD4CD25Foxp3 Tregs by liver sinusoidal endothelial cells.J Hepatol. 2014; Google Scholar, 14Dunham R.M. Thapa M. Velazquez V.M. Elrod E.J. Denning T.L. Pulendran B. et al.Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid.J Immunol. 2013; 190: 2009-2016Crossref PubMed Scopus (98) Google Scholar]. A more detailed phenotypic analysis of freshly isolated intra-hepatic Tregs with multi-colour flow cytometry would answer these questions particularly if this includes the TSDR methylation status, which correlates closely with stability and function of thymic derived Tregs [[15]Polansky J.K. Kretschmer K. Freyer J. Floess S. Garbe A. Baron U. et al.DNA methylation controls Foxp3 gene expression.Eur J Immunol. 2008; 38: 1654-1663Crossref PubMed Scopus (614) Google Scholar].AIH flares are characterized by high frequencies of both Tregs and effector T cells (Teffs) in the inflamed liver [8Lohr H.F. Schlaak J.F. Lohse A.W. Bocher W.O. Arenz M. Gerken G. et al.Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.Hepatology. 1996; 24: 1416-1421Crossref PubMed Google Scholar, 9Taubert R. Hardtke-Wolenski M. Noyan F. Wilms A. Baumann A.K. Schlue J. et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.J Hepatol. 2014; 61: 1106-1114Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar] (Fig. 1). Now Taubert and colleagues show that patients reaching biochemical remission have higher intrahepatic Treg/Teff and Treg/B cell ratios compared to those who fail to respond. This suggests that Tregs are important in gaining and maintaining remission. The finding that intrahepatic Tregs decrease during therapy is novel and particularly interesting and could explain the high relapse rates after discontinuation of immunosuppression. The authors’ data, showing that Tregs are more susceptible to particular forms of immunosuppression, suggest we should consider drugs that more specifically suppress effector cell responses. These observations are relevant for future therapy with infused Tregs and would suggest that Treg infusions will be most effective if used at induction or instead of maintaining immunosuppression. The current study reports that steroid and azathioprine therapy has a greater effect on intrahepatic Tregs compared with T effector cells [1Tait B. Mackay I.R. Board P. Coggan M. Emery P. Eckardt G. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.Gastroenterology. 1989; 97: 479-481Abstract Full Text PDF PubMed Google Scholar, 9Taubert R. Hardtke-Wolenski M. Noyan F. Wilms A. Baumann A.K. Schlue J. et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.J Hepatol. 2014; 61: 1106-1114Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar]. An important immunosuppressive mechanism of action of prednisolone/glucocorticoid is the inhibition of IL2 gene expression and two other commonly used immunosuppressive drugs, cyclosporine and tacrolimus; also reduce IL-2 production [[16]Granelli-Piperno A. Nolan P. Inaba K. Steinman R.M. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.J Exp Med. 1990; 172: 1869-1872Crossref PubMed Scopus (115) Google Scholar]. Tregs are highly dependent on IL-2 and this may explain the particular susceptibility of Tregs to treatment in the present study. Thus, it may be logical to use immunosuppressive drugs that preserve IL-2 mediated signalling in AIH.We have previously reported similar frequencies of intrahepatic effector and regulatory lymphocytes in liver tissue removed at transplantation from patients with autoimmune hepatitis [[6]Oo Y.H. Weston C.J. Lalor P.F. Curbishley S.M. Withers D.R. Reynolds G.M. et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol. 2010; 184: 2886-2898Crossref PubMed Scopus (171) Google Scholar] but the present study is the first to describe this in steroid-naïve patients. The consistent frequencies of intrahepatic Tregs show that there is no failure of Treg recruitment to the liver in AIH, and suggest it is the balance of Tregs and effector cells that will dictate the outcome. It is thus important to understand the factors within the hepatic microenvironment that determine differential or activation of Tregs and effector cells (Fig. in the present was that the frequency of B cells correlates with levels of that the levels that are characteristic of active AIH may be a of local intrahepatic is to understand the functional of local B cell activation in the liver and the of the The that on therapy the that is not expressed on cells suggests that may be by B cells within inflammatory in tissue consistent with the of the present study of to fall B cell with J Immunol. 2008; 38: PubMed Scopus Google important from the present study is that studies of Tregs in blood may not in have reported the frequency and function of Tregs in the peripheral blood of patients with autoimmune hepatitis G. D. et study of CD4+CD25+ regulatory T cells in and autoimmune Immunol. 2006; PubMed Scopus Google Scholar, M. M. B. F. Schwinge D. A. et regulatory T cells in autoimmune hepatitis are functional and not in Hepatol. Full Text Full Text PDF PubMed Scopus Google Scholar, S. C. C. P. A. et imbalance of T cells with regulatory function autoimmune hepatitis.Hepatology. 2010; PubMed Scopus Google which the of intrahepatic Tregs and not from analysis of the of hepatic in AIH may to and response to therapy as as to which patients have immunosuppression a high of the present study more on the important of intrahepatic Tregs effector T cells and B cells in autoimmune hepatitis. A detailed study of Tregs in the liver tissues and inflammation their local and function will of Tregs in autoimmune hepatitis (Fig. 1). than phenotypic studies are to the the but they are to of with clinical is as suggested in the current study. mechanisms in the human liver are more than previously and these will to more therapy in AIH that from was by the of authors that they not have to or of with to this Autoimmune hepatitis (AIH) is a classical autoimmune liver disease that has characteristic features of autoimmunity. It is more commonly seen in women, strongly associated with variants in the major histocompatibility complex region and usually responsive to immunosuppression. Although the aetiology is still unknown the development of the disease involves a loss of immunological self-tolerance to liver antigens resulting in a T cell mediated destruction of hepatocytes [[1]Tait B. Mackay I.R. Board P. Coggan M. Emery P. Eckardt G. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.Gastroenterology. 1989; 97: 479-481Abstract Full Text PDF PubMed Google Scholar]. The majority of AIH patients require lifelong immunosuppression to maintain remission and the treatment for AIH still relies on corticosteroids and azathioprine, which were first introduced more than 25 years ago [[2]Cook G.C. Mulligan R. Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.QJM. 1971; 40: 159-185Crossref PubMed Scopus (430) Google Scholar]. In recent years it has been suggested that one of the factors that predisposes to autoimmune disease is an imbalance between effector and regulatory arms of the immune system [3Sakaguchi S. Sakaguchi N. Asano M. Itoh M. Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.J Immunol. 1995; 155: 1151-1164PubMed Google Scholar, 4Putnam A.L. Safinia N. Medvec A. Laszkowska M. Wray M. Mintz M.A. et al.Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.Am J Transplant. 2013; 13: 3010-3020Crossref PubMed Scopus (200) Google Scholar]. Evidence of this comes not only from clinical studies but also from animal studies in which defects in immune regulation and a lack of functional regulatory T cells (Tregs) is associated with the development of autoimmunity including autoimmune hepatitis. However, it is less clear whether the defect in patients with AIH is due to a failure of regulatory cell recruitment or function, or whether regulatory cells are simply overwhelmed by dominant effector cell responses. The article by Taubert and colleagues in this edition of the Journal of Hepatology sheds more light on this debate. They conducted a correlative study using immunohistochemistry and flow cytometry to quantify the relative proportions of effector cells, regulatory T cells and B cells in the liver and blood of patients with type1 AIH. Consistent with other studies they reported that intrahepatic Tregs are enriched in untreated type1 AIH but that their numbers fall in response to therapy. The authors suggest that this effect of therapy might explain the high relapse rates seen after discontinuation of immunosuppression in AIH and speculate that therapies that increase or preserve intrahepatic immunoregulation might be better suited for the long-term control of AIH. comprise around 25% of intrahepatic immune cells and include effector CD4 T cells, cytotoxic T cells, B cells, invariant iNKT, and MAIT cells [[5]Racanelli V. Rehermann B. The liver as an immunological organ.Hepatology. 2006; 43: S54-S62Crossref PubMed Scopus (861) Google Scholar]. Regulatory networks particularly intrahepatic CD4+CD25highCD127lowFOXP3+ regulatory T cells control the effector responses. The intrahepatic frequency of these cells varies from 1% to 5% of the lymphocyte population in most chronic liver diseases [[6]Oo Y.H. Weston C.J. Lalor P.F. Curbishley S.M. Withers D.R. Reynolds G.M. et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol. 2010; 184: 2886-2898Crossref PubMed Scopus (171) Google Scholar] and is associated with a reversal of the CD4/CD8 ratio in the liver compared with blood [[7]Doherty D.G. O’Farrelly C. Innate and adaptive lymphoid cells in the human liver.Immunol Rev. 2000; 174: 5-20Crossref PubMed Scopus (307) Google Scholar]. In autoimmune hepatitis, CD4 T cells dominate in the early stage of the disease, particularly Th1 cells [[8]Lohr H.F. Schlaak J.F. Lohse A.W. Bocher W.O. Arenz M. Gerken G. et al.Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.Hepatology. 1996; 24: 1416-1421Crossref PubMed Google Scholar]. Subsequently, T helper cells recruit cytotoxic CD8 T cells leading to higher CD8 T cell frequencies and possibly more aggressive cytotoxic T cell mediated destruction of hepatocytes as the disease progresses as described by Taubert and colleagues [[9]Taubert R. Hardtke-Wolenski M. Noyan F. Wilms A. Baumann A.K. Schlue J. et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.J Hepatol. 2014; 61: 1106-1114Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar]. for the FOXP3 transcription factor, the master regulator of Treg differentiation and function has been widely used to quantify CD4 Tregs in tissues [[10]Fontenot J.D. Gavin M.A. Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.Nat Immunol. 2003; 4: 330-336Crossref PubMed Scopus (6020) Google Scholar]. However, FOXP3 is also expressed transiently during T cell activation and in some other lymphocyte subsets, potentially reducing the reliability of single colour immunohistochemistry to quantify Tregs in hepatic inflammation [6Oo Y.H. Weston C.J. Lalor P.F. Curbishley S.M. Withers D.R. Reynolds G.M. et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol. 2010; 184: 2886-2898Crossref PubMed Scopus (171) Google Scholar, 11Lan R.Y. Cheng C. Lian Z.X. Tsuneyama K. Yang G.X. Moritoki Y. et al.Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.Hepatology. 2006; 43: 729-737Crossref PubMed Scopus (258) Google Scholar]. The current report partially overcomes this by using double immunohistochemistry. However, in the inflamed environment some Tregs may display lineage plasticity and express both FOXP3 and the Th1 transcription factor TBet [[12]Yang X.O. Nurieva R. Martinez G.J. Kang H.S. Chung Y. Pappu B.P. et al.Molecular antagonism and plasticity of regulatory and inflammatory T cell programs.Immunity. 2008; 29: 44-56Abstract Full Text Full Text PDF PubMed Scopus (898) Google Scholar] and high local levels of TGF-β and retinoic acid may generate induced Tregs [13Carambia A. Freund B. Schwinge D. Heine M. Laschtowitz A. Huber S. et al.TGF-beta-dependent induction of CD4CD25Foxp3 Tregs by liver sinusoidal endothelial cells.J Hepatol. 2014; Google Scholar, 14Dunham R.M. Thapa M. Velazquez V.M. Elrod E.J. Denning T.L. Pulendran B. et al.Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid.J Immunol. 2013; 190: 2009-2016Crossref PubMed Scopus (98) Google Scholar]. A more detailed phenotypic analysis of freshly isolated intra-hepatic Tregs with multi-colour flow cytometry would answer these questions particularly if this includes the TSDR methylation status, which correlates closely with stability and function of thymic derived Tregs [[15]Polansky J.K. Kretschmer K. Freyer J. Floess S. Garbe A. Baron U. et al.DNA methylation controls Foxp3 gene expression.Eur J Immunol. 2008; 38: 1654-1663Crossref PubMed Scopus (614) Google Scholar]. AIH flares are characterized by high frequencies of both Tregs and effector T cells (Teffs) in the inflamed liver [8Lohr H.F. Schlaak J.F. Lohse A.W. Bocher W.O. Arenz M. Gerken G. et al.Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.Hepatology. 1996; 24: 1416-1421Crossref PubMed Google Scholar, 9Taubert R. Hardtke-Wolenski M. Noyan F. Wilms A. Baumann A.K. Schlue J. et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.J Hepatol. 2014; 61: 1106-1114Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar] (Fig. 1). Now Taubert and colleagues show that patients reaching biochemical remission have higher intrahepatic Treg/Teff and Treg/B cell ratios compared to those who fail to respond. This suggests that Tregs are important in gaining and maintaining remission. The finding that intrahepatic Tregs decrease during therapy is novel and particularly interesting and could explain the high relapse rates after discontinuation of immunosuppression. The authors’ data, showing that Tregs are more susceptible to particular forms of immunosuppression, suggest we should consider drugs that more specifically suppress effector cell responses. These observations are relevant for future therapy with infused Tregs and would suggest that Treg infusions will be most effective if used at induction or instead of maintaining immunosuppression. The current study reports that steroid and azathioprine therapy has a greater effect on intrahepatic Tregs compared with T effector cells [1Tait B. Mackay I.R. Board P. Coggan M. Emery P. Eckardt G. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.Gastroenterology. 1989; 97: 479-481Abstract Full Text PDF PubMed Google Scholar, 9Taubert R. Hardtke-Wolenski M. Noyan F. Wilms A. Baumann A.K. Schlue J. et al.Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies.J Hepatol. 2014; 61: 1106-1114Abstract Full Text Full Text PDF PubMed Scopus (102) Google Scholar]. An important immunosuppressive mechanism of action of prednisolone/glucocorticoid is the inhibition of IL2 gene expression and two other commonly used immunosuppressive drugs, cyclosporine and tacrolimus; also reduce IL-2 production [[16]Granelli-Piperno A. Nolan P. Inaba K. Steinman R.M. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter.J Exp Med. 1990; 172: 1869-1872Crossref PubMed Scopus (115) Google Scholar]. Tregs are highly dependent on IL-2 and this may explain the particular susceptibility of Tregs to treatment in the present study. Thus, it may be logical to use immunosuppressive drugs that preserve IL-2 mediated signalling in AIH. have previously reported similar frequencies of intrahepatic effector and regulatory lymphocytes in liver tissue removed at transplantation from patients with autoimmune hepatitis [[6]Oo Y.H. Weston C.J. Lalor P.F. Curbishley S.M. Withers D.R. Reynolds G.M. et al.Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.J Immunol. 2010; 184: 2886-2898Crossref PubMed Scopus (171) Google Scholar] but the present study is the first to describe this in steroid-naïve patients. The consistent frequencies of intrahepatic Tregs show that there is no failure of Treg recruitment to the liver in AIH, and suggest it is the balance of Tregs and effector cells that will dictate the outcome. It is thus important to understand the factors within the hepatic microenvironment that determine differential or activation of Tregs and effector cells (Fig. 1). A in the present was that the frequency of B cells correlates with levels of that the levels that are characteristic of active AIH may be a of local intrahepatic is to understand the functional of local B cell activation in the liver and the of the The that on therapy the that is not expressed on cells suggests that may be by B cells within inflammatory in tissue consistent with the of the present study of to fall B cell with J Immunol. 2008; 38: PubMed Scopus Google Scholar]. important from the present study is that studies of Tregs in blood may not in have reported the frequency and function of Tregs in the peripheral blood of patients with autoimmune hepatitis G. D. et study of CD4+CD25+ regulatory T cells in and autoimmune Immunol. 2006; PubMed Scopus Google Scholar, M. M. B. F. Schwinge D. A. et regulatory T cells in autoimmune hepatitis are functional and not in Hepatol. Full Text Full Text PDF PubMed Scopus Google Scholar, S. C. C. P. A. et imbalance of T cells with regulatory function autoimmune hepatitis.Hepatology. 2010; PubMed Scopus Google which the of intrahepatic Tregs and not from analysis of the of hepatic in AIH may to and response to therapy as as to which patients have immunosuppression a high of In the present study more on the important of intrahepatic Tregs effector T cells and B cells in autoimmune hepatitis. A detailed study of Tregs in the liver tissues and inflammation their local and function will of Tregs in autoimmune hepatitis (Fig. 1). than phenotypic studies are to the the but they are to of with clinical is as suggested in the current study. mechanisms in the human liver are more than previously and these will to more therapy in AIH that from immunosuppression. was by the was by the of authors that they not have to or of with to this The authors that they not have to or of with to this for for also for for to liver in

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.